Variability of Leser-Trélat Sign Secondary to Melanoma In Situ
- PMID: 38449989
- PMCID: PMC10917397
- DOI: 10.7759/cureus.53639
Variability of Leser-Trélat Sign Secondary to Melanoma In Situ
Abstract
Leser-Trélat sign (LTS) is characterized as an eruptive display of multiple seborrheic keratoses (SKs) in association with malignancy. This case highlights the variable presentation of LTS secondary to melanoma. To our knowledge, this LTS pattern is the first case where the sign manifests as a subtle pattern secondary to melanoma. This stands in contrast to the five documented cases in the literature of LTS-melanoma, which exhibited distinctive and eruptive patterns. A 64-year-old Caucasian female presented for a wellness examination. No personal history of skin cancer was noted. Patient displayed an onset proliferation of SKs with an irregular, sub-centimeter macular nevus over her right lateral mid back. A 6mm punch biopsy was significant for melanoma in situ, arising within a lentiginous compound dysplastic nevus, focally abutting one peripheral tissue edge. A re-excision with a minimum of 5mm margins was completed and the specimen was negative for residual in situ melanoma. Because of the rare occurrence of this delicate pattern at the site of the melanoma, this presentation adds to the knowledge surrounding this diagnosis. This case emphasizes the importance of maintaining vigilance regarding skin manifestations associated with disease and highlights the critical importance of observation and identification of subtle physical exam findings.
Keywords: cutaneous malignancy; leser-trélat sign; melanoma; seborrheic keratoses; variability.
Copyright © 2024, Silveri et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Leser-Trélat sign as a rare manifestation of cutaneous melanoma.Dermatol Reports. 2020 Jul 6;12(1):8665. doi: 10.4081/dr.2020.8665. eCollection 2020 Jun 25. Dermatol Reports. 2020. PMID: 32685126 Free PMC article.
-
Leser-Trélat Sign.2024 Feb 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Feb 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 29261959 Free Books & Documents.
-
The Pseudo-Sign of Leser-Trélat: A Rare Presentation.Cureus. 2023 Feb 18;15(2):e35155. doi: 10.7759/cureus.35155. eCollection 2023 Feb. Cureus. 2023. PMID: 36819974 Free PMC article.
-
Cutaneous T-cell lymphoma-associated Leser-Trélat sign: report and world literature review.Dermatol Online J. 2017 Jan 15;23(1):13030/qt0w01b1t3. Dermatol Online J. 2017. PMID: 28329468 Review.
-
Sign and pseudo-sign of Leser-Trélat: case reports and a review of the literature.J Drugs Dermatol. 2013 May;12(5):e79-87. J Drugs Dermatol. 2013. PMID: 23652964 Review.
References
-
- Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. Ellis DL, Kafka SP, Chow JC, Nanney LB, Inman WH, McCadden ME, King LE Jr. N Engl J Med. 1987;317:1582–1587. - PubMed
-
- The sign of Leser-Trélat associated with malignant melanoma. Fanti PA, Metri M, Patrizi A. https://pubmed.ncbi.nlm.nih.gov/2752795/ Cutis. 1989;44:39–41. - PubMed
-
- Leser-Trelat sign in metastasized malignant melanoma. Siedek V, Schuh T, Wollenberg A. Eur Arch Otorhinolaryngol. 2009;266:297–299. - PubMed
Publication types
LinkOut - more resources
Full Text Sources